Neurociencias
Departamento
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadoras/es de GlaxoSmithKline (United Kingdom) (4)
2022
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
2019
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
2015
-
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 1, Núm. 1, pp. 23-36
2000
-
Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex
Journal of Neurochemistry, Vol. 74, Núm. 3, pp. 1301-1309